Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 78, Issue 2, pp 895–897 | Cite as

Effect of hydrocortisone on the blood sugar and glycogenesis in rats with tumors

  • V. S. Shapot
  • V. A. Blinov
Biochemistry and Biophysics
  • 46 Downloads

Abstract

In fasting control rats and rats with tumors most exogenous glucose-C14 is utilized for glycogen synthesis in the liver only during the first 3 h after administration of hydrocortisone. In fasting rats with Zajdela's hepatoma the threshold of sensitivity of the liver tissue to the induction of glycogen synthesis by hydrocortisone and to the final hyperglycemic effect of this hormone is raised. The substrate induction of glycogenesis in the liver is not disturbed in rats with tumors.

Key Words

glycogen synthesis liver hydrocortisone Zajdela's hepatoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    V. A. Blinov, in: Tumor and Organism [in Russian], Kiev (1973), p. 40.Google Scholar
  2. 2.
    V. K. Gorodetskii, in: Modern Methods in Biochemistry [in Russian], Vol. 1, Moscow (1964), p. 311.Google Scholar
  3. 3.
    I. N. Kendysh, Probl. Endokrinol., No. 1, 86 (1972).Google Scholar
  4. 4.
    I. N. Kendysh, Uspekhi Sovr. Biol.,74, No. 3 (6), 369 (1972).Google Scholar
  5. 5.
    V. S. Misheneva, T. A. Goryukhina, T. M. Burova, et al., in: Tumor and Organism [in Russian], Kiev (1973), p. 216.Google Scholar
  6. 6.
    M. I. Prokhorova and Z. N. Tupikova, Large Textbook of Practical Carbohydrate and Lipid Metabolism [in Russian], Leningrad (1965).Google Scholar
  7. 7.
    S. B. Tagi-Zade, Azerbaidzhan. Med. Zh., No. 2, 27 (1971).Google Scholar
  8. 8.
    S. B. Tagi-Zade and V. S. Shapot, Vopr. Med. Khimii, No. 3, 254 (1970).Google Scholar
  9. 9.
    V. S. Shapot, in: Problems in Medical Chemistry [in Russian], Moscow (1973), p. 184.Google Scholar
  10. 10.
    W. H. H. Garvie and R. M. Grant, Brit. J. Cancer,25, 166 (1971).Google Scholar
  11. 11.
    P. Gullino et al., Cancer Res.,24, 780 (1967).Google Scholar
  12. 12.
    N. W. Hunter and C. Johnson, J. Cell. Comp. Physiol.,55, 275 (1960).Google Scholar
  13. 13.
    I. N. Kendysh and B. B. Moroz, Acta Endocrinol. (Copenhagen),71, 365 (1972).Google Scholar
  14. 14.
    T. Kostarz, Ann. Univ. M. Curie-Sklodowska,DD-17, 121 (1964).Google Scholar
  15. 15.
    M. A. Lea, P. Murphy, and H. P. Morris, Cancer Res.,32, 61 (1972).Google Scholar
  16. 16.
    K. Sato and S. Tsuiki, Cancer Res.,32 1451 (1972).Google Scholar
  17. 17.
    S. Tsuiki and R. Saheki, Gann Monogr.,1, 117 (1966).Google Scholar
  18. 18.
    V. S. Shapot, Advances Cancer Res.,15, 253 (1972).Google Scholar
  19. 19.
    G. Weber, R. L. Singhal, N. B. Stamm, et al., Advances Enzyme Reg.,2, 1 (1964).Google Scholar

Copyright information

© Plenum Publishing Corporation 1975

Authors and Affiliations

  • V. S. Shapot
    • 1
  • V. A. Blinov
  1. 1.Academy of Medical Sciences of the USSRUSSR

Personalised recommendations